1. Home
  2. KRUS vs EOLS Comparison

KRUS vs EOLS Comparison

Compare KRUS & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kura Sushi USA Inc.

KRUS

Kura Sushi USA Inc.

HOLD

Current Price

$58.73

Market Cap

683.6M

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$5.92

Market Cap

444.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRUS
EOLS
Founded
2008
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
683.6M
444.0M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
KRUS
EOLS
Price
$58.73
$5.92
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$84.29
$20.50
AVG Volume (30 Days)
300.4K
891.1K
Earning Date
01-07-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$282,763,000.00
$285,823,000.00
Revenue This Year
$18.91
$14.24
Revenue Next Year
$20.16
$21.77
P/E Ratio
N/A
N/A
Revenue Growth
18.88
15.10
52 Week Low
$40.03
$5.71
52 Week High
$106.60
$17.12

Technical Indicators

Market Signals
Indicator
KRUS
EOLS
Relative Strength Index (RSI) 62.72 29.49
Support Level $50.73 $6.57
Resistance Level $56.62 $6.80
Average True Range (ATR) 2.68 0.27
MACD 0.45 -0.12
Stochastic Oscillator 87.19 6.23

Price Performance

Historical Comparison
KRUS
EOLS

About KRUS Kura Sushi USA Inc.

Kura Sushi USA Inc is a technology-enabled Japanese restaurant concept that provides guests with a distinctive dining experience by serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. The company operates a network of dine-in locations across the U.S. states and Washington, DC.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: